The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...
Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized ...
The FDA approved Zepbound (tirzepatide ... The medication is not a replacement for CPAP therapy, which remains the first-line treatment for OSA. “This is the first drug treatment for obstructive ...
The U.S. Food and Drug Administration issued a rule to drastically reduce the amount of nicotine in cigarettes and other combusted tobacco products.
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Let freedom ryng: On Thursday, the Food and Drug Administration (FDA) authorized the marketing of 20 Zyn nicotine pouch ...
ZYN pouches contain no tobacco, only nicotine, offering a potentially less harmful option for tobacco users, with lower ...
The FDA has proposed cutting nicotine levels in cigarettes to non-addictive levels, aiming to curb smoking addiction and ...
“As the FDA has previously said, a proposed product standard to establish a maximum nicotine level to reduce the addictiveness of cigarettes and certain other combusted tobacco ...
The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb ... data” on Opdivo Qvantig and Yervoy combination therapy in NSCLC “to determine an appropriate ...